According to the Associated Press, the Institute of Medicine has selected six controversial dietary supplements to test the framework and process for evaluation of supplement safety in a program being developed for the Food and Drug Association.
The institute of Medicine, a branch of the National Academy of Sciences, said earlier this week that it had chosen chaparral, chromium picolinate, glucosamine, melatonin, saw palmetto and shark cartilage.
According to the AP article, the final version of the report is expected to go to the FDA in the fall, when the FDA will make the final decision on the investigations.
The FDA has not indicated whether it would do the evaluation internally, contract it out, or ask manufacturers to voluntarily submit data.
As part of the report, the institute has established guiding principles for supplement safety review, including a credible report of serious adverse events in humans; harm in laboratory animal studies and the presence of constituents similar to harmful compounds.